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Anthrax occurs in three clinical forms in humans: cuta- 
neous, gastrointestinal, and pulmonary Meningitis is rarely 
seen and is always fatal. It may be a complication of any 
of the three forms as a result of lymphohematogenous 
spread from the primary lesions or may develop as pri- 
mary infection, where anthrax is endemic. It is noted that 
about 100 cases with anthrax meningitis have been 
reported in the world literature.‘-* 
This report presents a case of hemorrhagic menin- 
gitis due to Bacillus anthracis. This is believed to be the 
second article about anthrax meningitis in Turkey. The 
first case was reported 12 years ago.5 
CASE REPORT 
A 64-year-old man was admitted to hospital with high 
fever, shortness of breath, and unconsciousness. His com- 
plaints had begun 3 days before his admission with 
malaise, headache, and abdominal pain. On examination, 
the patient was comatose and pupils were dilated. His 
temperature was 40°C pulse rate lbO/min, and respira- 
tory rate 40/min. His blood pressure was loo/60 mmHg. 
Neurologic examination revealed indefinite meningeal 
signs without neck rigidity, negative Kernig and Brudzin- 
ski signs and Babinski reflex. Cornea1 and deep tendon 
reflexes were both negative, and the patient did not 
respond to painful stimuli. His right retroauricular region 
and neck were slightly swollen and hyperemic, suggest- 
ing parotitis. There were no cutaneous lesions. 
Radiologic examination of the chest revealed enlarge- 
ment of the mediastinal lymph nodes, linear atelectasis, 
bronchiectasis, and minimal pleural effusion. Subamchnoid 
hemorrhage was found in cerebral computed tomography 
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White blood cell count was 18,500/mm3, and erythro- 
cyte sedimentation rate (ESR) was 21 mm/h. On lumbar 
puncture, cerebrospinal fluid (CSF) was projectile and hem- 
orrhagic. There were 200 white blood cells/mm3 with 90% 
polymorphonuclear leukocytes, 240 mg protein, and 5 
mg/dL glucose in CSE Smear of CSF revealed encapsulated 
gram-positive bacilli. Bacillus anthracis was isolated from 
cultures of CSF, blood, and the specimen aspirated from the 
parotid. The isolate was susceptible to penicillin, chlor- 
amphenicol, tetracycline, erythromycin, and ciprofloxacin. 
It was also sensitive to specific gamma phage. The isolate 
was inoculated into fresh blood and incubated at 37°C for 
6 hours, and encapsulation was observed. 
The patient, who was medicated empirically with 
penicillin, chloramphenicol, mannitol, and corticosteroids, 
did not respond to treatment and died 20 hours after 
admission. Autopsy was not performed. An epidemiologic 
investigation revealed that the patient was a wool and 
hide trader. All his family members were well after 9 
months, and no other death attributable to anthrax 
occurred in the village where he lived. 
DISCUSSION 
Anthrax is an endemic disease in Turkey, and between 
1990 and 1994,1779 human anthrax cases were recorded. 
Annual incidence of human anthrax cases is about 350. 
The majority of cases recorded were from the northeast- 
ern, eastern, and central parts of Turkey Most patients 
were agricultural workers. The notified human anthrax 
cases were cutaneous. A few cases of gastrointestinal 
anthrax are known to have been reported in Turkey, but 
inhalation anthrax has not been reported in Turkey yet.’ 
A case with anthrax meningitis developing from a cu- 
taneous lesion was reported in 1985.5 The present case 
is the second report of anthrax meningitis in Turkey. 
Anthrax is a sporadically occurring disease in Isparta, 
which is located in southwestern Turkey Only 13 cases 
have been reported in this region since 1985, all of which 
were cutaneous anthrax with agricultural origin6 Human 
cases of anthrax in an agricultural environment result from 
direct contact with animals that are sick or have died from 
anthrax. It is reported that 25 workers in one textile fac- 
tory contracted the disease, and the source was found to 
be goat hair imported from Pakistan.’ 
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Anthrax spores have several characteristics suitable 
for a biologic weapon, such as low visibility, high potency, 
accessibility, and relatively easy delivery, and they could 
be used not only in war but also for terrorist activities. 
Some countries have considered anthrax as a biologic 
warfare agent.* An epidemic of anthrax (77 cases and 66 
deaths) was caused by accidental release of anthrax 
spores in a narrow zone downwind of a Soviet military 
microbiology facility in Sverdlovsk in the Soviet Union.” 
The wool and hide trader described in this case may 
have become infected by inhalation or through direct 
contact with anthrax-contaminated animal wool or hide. 
This case is also a typical example of occupational expo- 
sure to the organism. Clinical and radiologic findings 
together with the history suggest that this case was 
inhalation anthrax complicated with meningitis. Autopsy 
could not be performed because of refusal by the family. 
The diagnosis was confirmed by isolation of 8. anthrucis 
from CSF, blood, and parotid aspirate cultures. 
Anthrax meningitis is an extremely rare entity. The 
most common portals of entry are skin (52.8%) and lungs 
(22.9%). About 11.5% of the cases are reported to be pri- 
mary anthrax meningitis. I0 In the case presented here, 
there were no external signs of injury or lesions, and the 
onset of the disease, as if a cold with cough and fever, 
might point to a respiratory entry. Sepsis was proved in 
this patient by isolation of the organism from blood. 
Pulmonary anthrax commonly follows a biphasic clin- 
ical pattern, with a benign initial phase followed by an 
acute, severe second phase that is almost always fatal. The 
initial phase begins as a nonspecific illness with malaise, 
low-grade fever, and dry cough, or it may resemble a mild 
upper respiratory tract infection as in the present case.” 
However, there is a sudden onset of respiratory distress 
and deterioration of the patient’s general status in pul- 
monary anthrax. Radiologic changes are of great sign& 
cance in establishing the diagnosis of inhalation anthrax. 
There is usually pleural effusion associated with marked 
widening of the mediastinal shadow owing to hemor- 
rhagic lymphadenitis.* The chest radiograph in the present 
case showed enlargement of the mediastinum, linear 
atelectasia, and pleural effusion. The average duration of 
the acute stage is reported to be less than 24 hours, almost 
always ending in death.” 
Several reports have described the development of 
an inflammatory lesion resembling a cutaneous lesion in 
the oral cavity, involving the posterior wall, the hard 
palate, or the tonsils, but the authors did not come across 
any reports showing that anthrax involves the parotid.‘2,1” 
In the present case, no lesion was noted in the oral cav- 
ity. Ingestion of contaminated meat or hematogenous 
spread of respiratory anthrax might cause oropharyngeal 
anthrax and parotitis; however, exclusive involvement of 
the parotid is unusual. 
Meningeal anthrax is described as a hemorrhagic 
meningitis in which intracranial arteritis is a prominent 
feature.14 Other findings, as exemplified by this case, include 
subarachnoid hemorrhage and hemorrhage. Definitive diag- 
nosis requires ex amining CSE Cerebrospinal fluid is com- 
monly hemorrhagic and has contained polymorphonuclear 
leukocytes and anthrax bacilli. Protein and glucose levels are 
like those in the other bacterial meningitides. Few patients 
have survived anthrax meningitis, despite use of antibiotics 
to which the organism is sensitive in vitro.’ The patient 
described here did not respond to antibiotic and support- 
ive therapy and died in a short period. 
The drug of choice in the treatment of anthrax is still 
penicillin, although isolates of penicillin-resistant B. m&rack 
have been reported. No penicillin-resistant B. antbruc-k infec- 
tion has been observed in Turkey.15 It has been suggested 
that the ideal therapy in meningitis and inhalation anthrax 
should include a specific antitoxic serum.2~3 
Control of the disease in humans depends on control 
of the disease in animals. Effective animal vaccines are 
available. A human anthrax vaccine is also available. In 
industry and agriculture, methods for protecting humans 
from contact with infectious material should be the pri- 
mary concern. 
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